Nuclear dreams: The malignant alteration of nuclear architecture

Journal of Cellular Biochemistry

Volumn 70, Issue 2, 1998, Pages 172-180

  Nickerson, Jeffrey A ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Cancer; Nuclear matrix; Nuclear structure

Indexed keywords

NUCLEAR PROTEIN; RIBONUCLEOPROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL NUCLEUS MATRIX; DNA REPLICATION; DROSOPHILA; DRUG TARGETING; GENE EXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; RAT; REVIEW; RNA SPLICING; RNA TRANSCRIPTION;

ANIMALS; ANTIGENS, NUCLEAR; CELL NUCLEUS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; NUCLEAR MATRIX; NUCLEAR PROTEINS; RNA, NUCLEAR;

ANIMALIA;

EID: 0031860097     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980801)70:2<172::AID-JCB3>3.0.CO;2-L     Document Type: Review

References (41)

1. Basta MT, Attallah AM, Seddek MN, el-Mohamady H, Al-Hilaly ES, Atwaan N, Ghoneim M (1988): Cytokeratin shedding in urine: A biological marker for bladder cancer? Br J Urol 61:116-121.
2. Benham C, Kohwi-Shigematsu T, Bode J (1997): Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J Mol Biol 274:181-196.
3. Berezney R (1979): Dynamic properties of the nuclear matrix. In Busch H (ed): "The Cell Nucleus," vol. 7. Orlando, FL: Academic Press, pp 413-456.
4. Berezney R, Mortillaro MJ, Ma H, Wei X, Samarabandu J (1995): The nuclear matrix: a structural milieu for genomic function. Int Rev Cytol 162A:1-65.
5. Bidwell JP, Fey EG, van Wijnen AJ, Penman S, Stein JL, Lian JB, Stein GS (1994): Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res. 54:28-32.
6. Blencowe BJ, Nickerson JA, Issner R, Penman S, Sharp PA (1994): Association of nuclear matrix antigens with exon-containing splicing complexes. J Cell Biol 127:593-607.
7. Blencowe BJ, Issner R, Nickerson JA, Sharp PA (1998): A nuclear matrix coactivator of RNA splicing. Gene Develop, in press.
8. Catapano CV, Carbone GM, Fernandes DJ (1996): The nuclear matrix as a target for cancer therapy. Ann Oncol 7:659-666.
9. Chiusa L, Galliano D, Formiconi A, Di Primio O, Pich A (1997): High- and low-risk prostate carcinoma determined by histologic grade and proliferative activity. Cancer 79:1956-1963.
10. Clemson CM, McNeil JA, Willard HF, Lawrence JB (1996): XIST RNA paints the inactive X chromosome at interphase: Evidence for a novel RNA involved in nuclear/ chromosome structure. J. Cell Biol. 132:259-275.
11. Dominguez-Malagon HR, Szymanski-Gomez JJ, Gaytan-Garcia SR (1988): Optically clear and vacuolated nuclei: Two useful signs for the transoperative diagnosis of papillary carcinoma of the thyroid. Cancer 62:105-108.
12. Getzenberg RH, Coffey DS (1991): Identification of nuclear matrix proteins in the cancerous and normal rat prostate. Cancer Res 51:6514-6520.
13. Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR (1996): Bladder cancer-associated nuclear matrix proteins. Cancer Res 56:1690-1694.
14. He DC, Nickerson JA, Penman S (1990): Core filaments of the nuclear matrix. J Cell Biol 110:569-580.
15. Ingber DE (1997): Tensegrity: The architectural basis of cellular mechanotransduction. Annu Rev Physiol 59:575-599.
16. Jackson DA, Cook PR (1988): Visualization of a filamentous nucleoskeleton with a 23-nm axial repeat. Embo J 7:3667-3677.
17. Keesee SK, Meneghini M, Szaro RP, Wu Y-J (1994): Nuclear matrix proteins in colon cancer. Proc Natl Acad Sci USA 91:1913-1916.
18. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ (1993): Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53:3394-3398.
19. Mancini MG, Liu B, Sharp ZD, Mancini MA (1998): Sub-nuclear partitioning and functional regulation of the Pit-1 transcription factor. J. Cell. Biochem. 70:in press.
20. Mattern KA, Humbel BM, Muijsers AO, de Jong L, van Driel R (1996): hnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J Cell Biochem 62:275-289.
21. McCaffery JD, Gapany M, Faust RA, Davis AT, Adams GL, Ahmed K (1997): Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123:283-288.
22. Naik H, Lehr JE, Pienta KJ (1996): Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine. Urology 48:508-511.
23. Nickerson JA, Penman S (1992): Localization of nuclear matrix core filament proteins at interphase and mitosis. Cell Biol Int Rep 16:811-826.
24. Nickerson JA, Blencowe BJ, Penman S (1995): The architectural organization of nuclear metabolism. Intl Rev Cytol 162A:67-123.
25. Nickerson JA, Krockmalnic G, Wan KM, Penman S (1997): The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proc Natl Acad Sci USA 94:4446-4450.
26. Pariente JL, Bordenave L, Michel P, Latapie MJ, Ducassou D, Le Guillou M (1997): Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma. J Urol 158:338-341.
27. Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI (1992): Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 70:161-168.
28. Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS (1993): Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53:744-746.
29. Partin AW, Briggman JV, Subong EN, Szaro R, Oreper A, Wiesbroek S, Meyer J, Coffey DS, Epstein JI (1997): Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins. Urology 50:800-808.
30. Picnta KJ, Murphy BC, Getzenberg RH, Coffey DS (1993): The tissue matrix and regulation of gene expression in cancer cells. Adv Mol Cell Biol 7:131-156.
31. Replogle-Schwab TS, Pienta KJ, Getzenberg RH (1996): The utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryo Gene Exp 6:103-113.
32. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT (1994): Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25:249-265.
33. Samuel SK, Minish TM, Davie JR (1997): Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines. J Cell Biochem 66:9-15.
34. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, Lange P, Messing E, Pasciak RM, Reservitz GB, Rukstalis DB, Sarosdy MF, Stadler WM, Thiel RP, Hayden CL (1996): Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156:363-367.
35. van Velthoven R, Petein M, Oosterlinck WJ, Zandona C, Zlotta A, Van der Meijden AP, Pasteels JL, Roels H, Schulman C, Kiss R (1995): Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. Hum Pathol 26:3-11.
36. Veltri RW, Miller MC, Partin AW, Coffey DS, Epstein JI (1996): Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. Urology 48:685-91.
37. Weaver VM, Fischer AH, Peterson OW, Bissell MJ (1996): The importance of the microenvironment in breast cancer progression: Recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 74:833-851.
38. Yanagisawa J, Ando J, Nakayama J, Kohwi Y, Kohwi-Shigematsu T (1996): Amatrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues. Cancer Res 56:457-462.
39. Zeitlin S, Parent A, Silverstein S, Efstratiadis A (1987): Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol 7:111-120.
40. Zeitlin S, Wilson RC, Efstradiadis A (1989): Autonomous splicing and complementation of in vivo assembled splicosomes. J Cell Biol 108:765-777.
41. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW (1997): Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/ CBF-alpha transcription factors. Proc Natl Acad Sci USA 94:6746-6751.